Atrial Fibrillation Institute, Mater Private Network, 72 Eccles Street, Dublin 7, D07 RD8P, Ireland.
Health Sciences Centre, UCD School of Medicine, University of College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
Europace. 2023 Apr 15;25(4):1345-1351. doi: 10.1093/europace/euad029.
Incorporating a steerable sheath that can be visualized using an electroanatomical mapping (EAM) system may allow for more efficient mapping and catheter placement, while reducing radiation exposure, during ablation procedures for atrial fibrillation (AF). This study evaluated fluoroscopy usage and procedure times when a visualizable steerable sheath was used compared with a non-visualizable steerable sheath for catheter ablation for AF.
In this retrospective, observational, single-centre study, patients underwent catheter ablation for AF using a steerable sheath that is visualizable using the CARTO EAM (VIZIGO; n = 57) or a non-visualizable steerable sheath (n = 34). The acute procedural success rate was 100%, with no acute complications in either group. Use of the visualizable sheath vs. the non-visualizable sheath was associated with a significantly shorter fluoroscopy time [median (first quartile, third quartile), 3.4 (2.1, 5.4) vs. 5.8 (3.8, 8.6) min; P = 0.003], significantly lower fluoroscopy dose [10.0 (5.0, 20.0) vs. 18.5 (12.3, 34.0) mGy; P = 0.015], and significantly lower dose area product [93.0 (48.0, 197.9) vs. 182.2 (124.5, 355.0) μGy·m2; P = 0.017] but with a significantly longer mapping time [12.0 (9.0, 15.0) vs. 9.0 (7.0, 11.0) min; P = 0.004]. There was no significant difference between the visualizable and non-visualizable sheaths in skin-to-skin time [72.0 (60.0, 82.0) vs. 72.0 (55.5, 80.8) min; P = 0.623].
In this retrospective study, use of a visualizable steerable sheath for catheter ablation of AF significantly reduced radiation exposure vs. a non-visualizable steerable sheath. Although mapping time was longer with the visualizable sheath, the overall procedure time was not increased.
在房颤消融过程中,使用可操控鞘管并能通过电解剖标测系统(EAM)可视化,可能有助于更有效地进行标测和导管放置,同时减少辐射暴露。本研究评估了在房颤导管消融中,与非可视可操控鞘管相比,可视可操控鞘管的使用对透视时间和手术时间的影响。
在这项回顾性、观察性、单中心研究中,使用可通过 CARTO EAM 可视化的可操控鞘管(VIZIGO;n=57)或不可视可操控鞘管(n=34)对房颤患者进行导管消融。两组的急性手术成功率均为 100%,均无急性并发症。与不可视可操控鞘管相比,可视可操控鞘管的使用与透视时间明显缩短[中位数(第一四分位数,第三四分位数),3.4(2.1,5.4)vs.5.8(3.8,8.6)min;P=0.003]、透视剂量明显降低[10.0(5.0,20.0)vs.18.5(12.3,34.0)mGy;P=0.015]和剂量面积乘积明显降低[93.0(48.0,197.9)vs.182.2(124.5,355.0)μGy·m2;P=0.017],但标测时间明显延长[12.0(9.0,15.0)vs.9.0(7.0,11.0)min;P=0.004]。可视鞘和不可视鞘的皮肤到皮肤时间无显著差异[72.0(60.0,82.0)vs.72.0(55.5,80.8)min;P=0.623]。
在这项回顾性研究中,与非可视可操控鞘管相比,房颤导管消融中使用可视可操控鞘管可显著降低辐射暴露。尽管可视鞘管的标测时间较长,但总手术时间并未增加。